In addition, the mutations in genes involved in DNA methylation (e.g., DNMT3A, IDH1/2, TET2) play an important role in genome-wide methylation signature in AML and contribute to the leukemogenesis and prognosis [16, 53, 67–69]. Here, DNMT3A is linked to acute myeloid leukemia.